Group 1 - The latest stock price of Duori Pharmaceutical is 37.76 yuan, an increase of 0.85 yuan from the previous trading day, with a highest intraday price of 38.07 yuan and a lowest of 36.37 yuan [1] - The company operates in the chemical pharmaceutical industry, focusing on the research and production of pharmaceutical products, including chemical drugs and traditional Chinese medicine [1] - The product line includes Yifei Jisheng granules, which is a Class 1 new traditional Chinese medicine currently undergoing Phase II clinical trials [1] Group 2 - Duori Pharmaceutical stated on the investor interaction platform that the research and development of Yifei Jisheng granules is progressing as planned, emphasizing the long cycle and high uncertainty associated with pharmaceutical R&D [1] - The net outflow of main funds on the day was 2.0484 million yuan, with a cumulative net outflow of 23.9297 million yuan over the past five trading days [1]
多瑞医药股价上涨2.3% 中药1类新药进入Ⅱ期临床